Brain atrophy and lesion load predict long term disability in multiple sclerosis V Popescu, F Agosta, HE Hulst, IC Sluimer, DL Knol, MP Sormani, ... Journal of Neurology, Neurosurgery & Psychiatry 84 (10), 1082-1091, 2013 | 395 | 2013 |
Subcortical atrophy and cognition: sex effects in multiple sclerosis MM Schoonheim, V Popescu, FC Rueda Lopes, OT Wiebenga, ... Neurology 79 (17), 1754-1761, 2012 | 255 | 2012 |
Optimizing parameter choice for FSL-Brain Extraction Tool (BET) on 3D T1 images in multiple sclerosis V Popescu, M Battaglini, WS Hoogstrate, SCJ Verfaillie, IC Sluimer, ... Neuroimage 61 (4), 1484-1494, 2012 | 210 | 2012 |
Relevance of spinal cord abnormalities to clinical disability in multiple sclerosis: MR imaging findings in a large cohort of patients C Lukas, MH Sombekke, B Bellenberg, HK Hahn, V Popescu, K Bendfeldt, ... Radiology 269 (2), 542-552, 2013 | 173 | 2013 |
Cervical spinal cord volume loss is related to clinical disability progression in multiple sclerosis C Lukas, DL Knol, MH Sombekke, B Bellenberg, HK Hahn, V Popescu, ... Journal of Neurology, Neurosurgery & Psychiatry 86 (4), 410-418, 2015 | 156 | 2015 |
Smouldering multiple sclerosis: the ‘real MS’ G Giovannoni, V Popescu, J Wuerfel, K Hellwig, E Iacobaeus, MB Jensen, ... Therapeutic advances in neurological disorders 15, 17562864211066751, 2022 | 151 | 2022 |
What drives MRI-measured cortical atrophy in multiple sclerosis? V Popescu, R Klaver, P Voorn, Y Galis-de Graaf, D Knol, J Twisk, ... Multiple Sclerosis Journal, 2015 | 123 | 2015 |
Effects of an individual 12-week community-located “start-to-run” program on physical capacity, walking, fatigue, cognitive function, brain volumes, and structures in persons … P Feys, L Moumdjian, F Van Halewyck, I Wens, BO Eijnde, ... Multiple Sclerosis Journal 25 (1), 92-103, 2019 | 111 | 2019 |
Functional adaptive changes within the hippocampal memory system of patients with multiple sclerosis HE Hulst, MM Schoonheim, SD Roosendaal, V Popescu, LJS Schweren, ... Human brain mapping 33 (10), 2268-2280, 2012 | 106 | 2012 |
Neuronal and axonal loss in normal-appearing gray matter and subpial lesions in multiple sclerosis R Klaver, V Popescu, P Voorn, Y Galis-de Graaf, P van der Valk, ... Journal of Neuropathology & Experimental Neurology 74 (5), 453-458, 2015 | 87 | 2015 |
Oxysterols and cholesterol precursors correlate to magnetic resonance imaging measures of neurodegeneration in multiple sclerosis C Van de Kraats, J Killestein, V Popescu, E Rijkers, H Vrenken, ... Multiple Sclerosis Journal 20 (4), 412-417, 2014 | 82 | 2014 |
Machine learning analysis of motor evoked potential time series to predict disability progression in multiple sclerosis J Yperman, T Becker, D Valkenborg, V Popescu, N Hellings, ... BMC neurology 20, 1-15, 2020 | 66 | 2020 |
Grey Matter Atrophy in Multiple Sclerosis: Clinical Interpretation Depends on Choice of Analysis Method V Popescu, MM Schoonheim, A Versteeg, N Chaturvedi, M Jonker, ... PLoS One 11 (1), 2016 | 66 | 2016 |
Identification of biomarkers for diagnosis and progression of MS by MALDI-TOF mass spectrometry CE Teunissen, MJA Koel-Simmelink, TV Pham, JC Knol, M Khalil, ... Multiple Sclerosis Journal 17 (7), 838-850, 2011 | 56 | 2011 |
Intercenter agreement of brain atrophy measurement in multiple sclerosis patients using manually‐edited SIENA and SIENAX B Jasperse, P Valsasina, V Neacsu, DL Knol, N De Stefano, C Enzinger, ... Journal of Magnetic Resonance Imaging: An Official Journal of the …, 2007 | 54 | 2007 |
Predicting clinical progression in multiple sclerosis after 6 and 12 years I Dekker, AJC Eijlers, V Popescu, LJ Balk, H Vrenken, MP Wattjes, ... European journal of neurology 26 (6), 893-902, 2019 | 53 | 2019 |
Accurate GM atrophy quantification in MS using lesion-filling with co-registered 2D lesion masks V Popescu, NCG Ran, F Barkhof, DT Chard, CA Wheeler-Kingshott, ... NeuroImage: Clinical 4, 366-373, 2014 | 52 | 2014 |
Motor evoked potential: a reliable and objective measure to document the functional consequences of multiple sclerosis? Relation to disability and MRI NF Kalkers, RLM Strijers, MMS Jasperse, V Neacsu, JJG Geurts, ... Clinical neurophysiology 118 (6), 1332-1340, 2007 | 48 | 2007 |
Postmortem validation of M RI cortical volume measurements in MS V Popescu, R Klaver, A Versteeg, P Voorn, JWR Twisk, F Barkhof, ... Human brain mapping 37 (6), 2223-2233, 2016 | 40 | 2016 |
Sativex®(nabiximols) cannabinoid oromucosal spray in patients with resistant multiple sclerosis spasticity: the Belgian experience M D’hooghe, B Willekens, V Delvaux, M D’haeseleer, D Guillaume, ... BMC neurology 21 (1), 227, 2021 | 33 | 2021 |